Effects of microRNA-21 on the biological functions of T-cell acute lymphoblastic lymphoma/leukemia

Cunzhen Shi(First Affiliated Hospital of Zhengzhou University), Mingzhi Zhang(Soochow University)

Oncology Letters

September 21, 2016

10.3892/ol.2016.5163

Cited by 12

Related Papers

CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

|Blood|2013|247

Efficacy and Safety of a Pegasparaginase-Based Chemotherapy Regimen vs an L-asparaginase–Based Chemotherapy Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell Lymphoma

|JAMA Oncology|2022|61

A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphoma

|Journal of Hematology & Oncology|2020|50

Recurrent GNAQ mutation encoding T96S in natural killer/T cell lymphoma

|Nature Communications|2019|34

<p>Anti-PD1 up-regulates PD-L1 expression and inhibits T-cell lymphoma progression: possible involvement of an IFN-&gamma;-associated JAK-STAT pathway</p>

|OncoTargets and Therapy|2019|31